A detailed history of Planned Solutions, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Planned Solutions, Inc. holds 4,370 shares of JNJ stock, worth $669,658. This represents 0.29% of its overall portfolio holdings.

Number of Shares
4,370
Previous 3,403 28.42%
Holding current value
$669,658
Previous $497,000 42.45%
% of portfolio
0.29%
Previous 0.24%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$145.48 - $167.38 $140,679 - $161,856
967 Added 28.42%
4,370 $708,000
Q2 2024

Jul 24, 2024

SELL
$144.38 - $157.78 $42,592 - $46,545
-295 Reduced 7.98%
3,403 $497,000
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $310 - $325
2 Added 0.05%
3,698 $584,000
Q4 2023

Jan 17, 2024

SELL
$145.6 - $158.88 $57,512 - $62,757
-395 Reduced 9.66%
3,696 $579,000
Q3 2023

Feb 06, 2024

BUY
$155.75 - $174.48 $14,017 - $15,703
90 Added 2.44%
3,786 $589,000
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $308 - $332
2 Added 0.05%
4,091 $677,000
Q1 2023

Apr 12, 2023

BUY
$151.05 - $180.26 $151 - $180
1 Added 0.02%
4,089 $633,000
Q4 2022

Jan 25, 2023

BUY
$160.2 - $179.79 $20,025 - $22,473
125 Added 3.15%
4,088 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $47,108 - $52,419
292 Added 7.95%
3,963 $647,000
Q2 2022

Jul 14, 2022

BUY
$168.19 - $186.01 $6,054 - $6,696
36 Added 0.99%
3,671 $652,000
Q1 2022

Apr 08, 2022

SELL
$158.14 - $179.59 $4,269 - $4,848
-27 Reduced 0.74%
3,635 $644,000
Q4 2021

Feb 03, 2022

BUY
$155.93 - $173.01 $28,691 - $31,833
184 Added 5.29%
3,662 $626,000
Q2 2021

Jul 21, 2021

BUY
$159.48 - $171.07 $318 - $342
2 Added 0.06%
3,478 $573,000
Q1 2021

Apr 29, 2021

SELL
$153.07 - $170.48 $26,787 - $29,834
-175 Reduced 4.79%
3,476 $571,000
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $13,985 - $16,052
102 Added 2.87%
3,651 $575,000
Q3 2020

Nov 06, 2020

BUY
$140.38 - $153.83 $498,208 - $545,942
3,549 New
3,549 $528,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Planned Solutions, Inc. Portfolio

Follow Planned Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planned Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Planned Solutions, Inc. with notifications on news.